As part of a mentorship program uniting UGA students with Publicis Health professionals, we were paired during the Cannes Lions Health Festival. And, although, we’re from totally different generations and backgrounds, and at different places career-wise, we were surprised by how much our experiences had in common.

They say it’s the light in the south of France that attracted so many of our favorite artists – Picasso, Cezanne, Matisse, and Leger, among others – all drawn to those magical low hills tumbling into the sea, bathed in a uniquely clear and warm light. But writers came there also – were Fitzgerald and Baldwin also mesmerized by the light, or was it the calm that allowed their creative minds to run free?

After two years of judging this show, it was interesting and comparatively relaxing to be an attendee at this year’s Lions Health.

I guess most people coming from Cannes might be struck by the latest trends in healthcare communications – the penetration of digital, the rise of the informed patient and the continued dominance in the prizes of ‘Good Causes’ rather than product promotion. However for me the biggest and most dominant theme that emerged both in observing the attendees, and also in talking to my peers across the industry from all specialties and geographies, was talent – or to be precise the lack of it.

As another year has come and gone it’s time for creative types to review the highlights from Cannes Lions 2016. Ten trends emerged throughout the judging process and the festival itself. These trends are not just advertising trends, but rather principles and values for success in business.

Executives from leading healthcare communications agencies and networks came together on July 18th at the headquarters of Ogilvy Worldwide in New York City for the Medical Advertising Hall of Fame’s (MAHF) “View from the Top” event. Young professionals from the healthcare advertising industry were invited to hear first-hand from CEOs, presidents, and other management on what it takes to be a leader.

The two leading biopharmaceutical organizations made a bold public statement on FDA off-label policy that proposes new regulatory standard that provides a great starting point for the inevitable policy debates on how the FDA defines “false and misleading” in marketing.

To build brands in this most personal of industries, healthcare marketers must first make the human connection.

Understanding the nuances of your brand’s healthcare professional audience(s) can improve marketing strategies and make your media dollars work harder.

An ever-shifting sales landscape calls for a nimble, responsive sales approach – one often problematic for the behemoth infrastructures of many large pharmaceutical organizations and the experience level of emerging biotechnology firms. As a result, commercial services partners offer a stronger than ever value proposition to the industry.